Cite
HARVARD Citation
Shitara, K. et al. (2019). REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients. Annals of oncology. pp. 259-265. [Online].